why choose us

First received: May 01, 2023

Clinical Trial: Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adult Gliomas, Mixed

Study Type: INTERVENTIONAL


Official Title: Hyperpolarized Carbon-13 Alpha-ketoglutarate Metabolic Imaging in IDH Mutant Glioma

Brief Summary: This study will investigate the use of hyperpolarized (HP) carbon-13 (13C) alpha-ketoglutarate (aKG) (HP 13C-aKG) to characterize tumor burden in patients with isocitrate dehydrogenase (IDH) mutant glioma.

Read more